Adam Johns

Adam Johns is a highly accomplished professional with a diverse educational background and extensive experience in the fields of data science, health economics, and market access.

He holds a Master of Information and Data Science (MIDS) from UC Berkeley School of Information, specializing in data science, data engineering, and machine learning. Additionally, he obtained a Master of Science (MSc) in International Health Policy and Health Economics from the London School of Economics and Political Science, as well as a Bachelor of Science (BSc) in Science and Business, with a focus on Economics, from the University of Waterloo.

Adam currently serves as the Digital, Methods and Modeling Lead for Global Value & Evidence in the Oncology division at Novartis. Prior to his role at Novartis, he held several significant positions in renowned organizations including being an MSc Student at UC Berkeley School of Information, Principal of Pricing and Market Access at ICON plc, Director of Payer Insights and Access in Oncology at Pfizer, Outcomes Research Manager in Oncology at Pfizer, and Health Outcomes Scientist in European Outcomes Research at Eli Lilly and Company.